Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Report
May 27, 2024
Bristol-Myers Squibb -Therapeutic Portfolios | Respiratory | Company & Drug | Global | 2024
The document complements our standalone (detailed) company profile (which emphasis on clinical aspects more) by adding the business facet covering overall strategy, Geographical focus, Therapy…
Report
April 12, 2024
Idiopathic Pulmonary Fibrosis – Unmet Need – Unmet Need – Idiopathic Pulmonary Fibrosis (US/EU)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder associated with progressive inflammation and/or fibrosis of the lung tissue. The leading cause of the disorder is unknown. IPF…
Report
March 1, 2024
Sarcoidosis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Sarcoidosis (US)
Sarcoidosis is a rare inflammatory disease that causes the formation of granulomas—small lumps or nodules. Although it primarily affects the lungs, it can involve multiple organs, including the…
